News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aslan Pharma of Singapore Raises $12 Million for In-licensing


4/28/2011 8:50:08 AM

April 27, 2011 -- Aslan Pharmaceuticals Pte. Ltd. of Singapore announced a $12 million Series A funding, which it will use to in-license novel medicines. The company’s business model is to partner development-stage drugs that are 6-12 months from entering the clinic, perform Phase I and II studies in Asia to obtain Proof of Concept, and then out-license the compounds back to partners for global development. More details....

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES